The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial-Reference-Cited by-同舟云学术

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

Published:2015-10 Issue:10 Volume:15 Page:1156-1166
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Huttner Angela,Dayer Julie-Anne,Yerly Sabine,Combescure Christophe,Auderset Floriane,Desmeules Jules,Eickmann Markus,Finckh Axel,Goncalves Ana Rita,Hooper Jay W,Kaya Gürkan,Krähling Verena,Kwilas Steve,Lemaître Barbara,Matthey Alain,Silvera Peter,Becker Stephan,Fast Patricia E,Moorthy Vasee,Kieny Marie Paule,Kaiser Laurent,Siegrist Claire-Anne

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference35 articles.

1. WHO. WHO Situation Report. http://apps.who.int/ebola/current-situation/ebola-situation-report-17-june-2015 (accessed June 22, 2015).

2. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections;Geisbert;J Infect Dis,2011

3. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses;Jones;Nat Med,2005

4. Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong Ebola GP-specific immune responses;Qiu;PLoS One,2009

5. Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates;Geisbert;PLoS Pathog,2008

Cited by 250 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon;Journal of Infection;2024-10

2. Knowledge, attitudes, and practices and long-term immune response after rVSVΔG-ZEBOV-GP Ebola vaccination in healthcare workers in high-risk districts in Uganda;Vaccine;2024-09

3. An efficient plasmid-based system for the recovery of recombinant vesicular stomatitis virus encoding foreign glycoproteins;Scientific Reports;2024-06-25

4. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice;Journal of Virology;2024-06-13

5. Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques;Vaccines;2024-03-29